Testosterone replacement therapy (TRT) does not worsen oncologic outcomes in hypogonadal men with prostate cancer, according to study findings presented at the Canadian Urological Association 2016 annual meeting in Vancouver.
http://www.renalandurologynews.com/...-for-men-with-prostate-cancer/article/505807/
http://www.renalandurologynews.com/...-for-men-with-prostate-cancer/article/505807/
